InvestorsHub Logo
Followers 30
Posts 5057
Boards Moderated 0
Alias Born 01/07/2020

Re: lizzy241 post# 302887

Saturday, 10/03/2020 4:46:10 PM

Saturday, October 03, 2020 4:46:10 PM

Post# of 426271
lizzy@ You are referring to this:

https://www.hikma.com/media/2836/vascepa-statement-september-2020-vfinal.pdf

Vascepa®
is a prescription medicine that is indicated, in part, as an adjunct to diet to reduce triglyceride
levels in adult patients with severe (= 500 mg/dL) hypertriglyceridemia. According to IQVIA, US sales of
Vascepa® were approximately $1.1 billion in the 12 months ending July 2020.



We have to remember that little 'One Drug' Amarin - are up against Giants here - Hikma and Dr. Reddy - for whom these ANDA Lawsuit's are 'what they do' all year around.

https://www.hikma.com/products/

690 Products (roll down the site)

Win over Amarin - bringing Vascepa to line of products - a small notice on the frontpage.

https://www.hikma.com/home/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News